Erlotinib for the treatment of relapsed non-small cell lung cancer. [electronic resource]
Producer: 20090922Description: 41-7 p. digitalISSN:- 2046-4924
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cost-Benefit Analysis
- Erlotinib Hydrochloride
- Humans
- Lung Neoplasms -- drug therapy
- Neoplasm Recurrence, Local
- Protein Kinase Inhibitors -- economics
- Quality-Adjusted Life Years
- Quinazolines -- economics
- Randomized Controlled Trials as Topic
- Survival Analysis
- Technology Assessment, Biomedical
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.